Table II.
Demographic, clinical, and laboratory data for patients who underwent surgery in our study
| Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | Case 6 | Case 7 | Case 8 | Case 9 | Case 10 | Case 11 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sex | Female | Female | Female | Female | Male | Male | Female | Female | Male | Female | Male |
| Age (yr) | 86 | 74 | 64 | 58 | 55 | 43 | 84 | 73 | 50 | 60 | 66 |
| ASA score | II | II | II | II | II | II | II | II | II | II | II |
| Comorbidity | HBP, DLP, A-fib | HBP | DLP | Fibromyalgia | Diabetes, DLP, BPH | Polytrauma with thoracic vertebral fracture, pelvis fracture, PFF | Diabetes, hypothyroidism, DLP | Asthma, DLP, PFF | HBP | HBP | HBP |
| Orthopedic diagnosis | Proximal humerus fracture | Humerus shaft fracture | Proximal humerus fracture | Proximal humerus fracture | Proximal humerus fracture | Proximal humerus fracture | Humerus shaft fracture | Proximal humerus fracture | Proximal humerus fracture | Proximal humerus fracture | Proximal humerus fracture |
| Orthopedic procedure | rTSA | ORIF with humeral nail and cerclages | ORIF with proximal humeral plate | ORIF with proximal humeral plate | ORIF with proximal humeral plate | ORIF with proximal humeral plate | ORIF with humeral nail and cerclages | ORIF with proximal humeral plate | ORIF with proximal humeral plate | ORIF with proximal humeral plate | ORIF with proximal humeral plate |
| Date of fracture | March 4 | March 13 | March 14 | March 15 | March 21 | February 28 | April 2 | April 21 | April 22 | April 25 | April 22 |
| Date of admission | March 13 | March 17 | March 18 | March 18 | March 25 | February 28 | April 22 | April 21 | April 29 | April 29 | April 29 |
| Orthopedic operation | March 13 | March 17 | March 18 | March 18 | March 25 | March 27 | April 22 | April 24 | April 29 | April 29 | April 29 |
| Date of discharge | March 16 | March 20 | March 19 | March 20 | March 27 | Remained in hospital | April 25 | April 26 | April 30 | May 1 | May 7 |
| Surgical duration (min) | 80 | 110 | 84 | 80 | 75 | 150 | 100 | 90 | 95 | 160 | 90 |
| Hospital length stay (d) | 3 | 3 | 1 | 2 | 2 | Remained in hospital | 3 | 5 | 1 | 3 | 1 |
| Laboratory test results | |||||||||||
| Hemoglobin (g/dL) | 12.9 | 11.9 | 13 | 14.6 | 14 | 12 | 13.2 | 15.2 | 13.1 | 13.7 | 14.1 |
| White blood cell count (×109/L) | 17.2 | 12.2 | 10.62 | 6.97 | 15.63 | 10.78 | 5.79 | 13.2 | 10.9 | 17.66 | 7.4 |
| Neutrophil count (×109/L) | 14.4 | 7.9 | 6.9 | 4.1 | 12.3 | 8.2 | 3.4 | 9.4 | 8 | 15.6 | 5.6 |
| Lymphocyte count (×109/L) | 1.8 | 2.9 | 2.2 | 2 | 1.3 | 1.6 | 1.8 | 2.8 | 1.8 | 0.8 | 1.2 |
| Monocyte count (×109/L) | 0.9 | 1.1 | 1.5 | 0.7 | 1.5 | 0.6 | 0.5 | 0.7 | 1 | 1.3 | 0.5 |
| Platelet count (×109/L) | 264 | 256 | 288 | 253 | 189 | 647 | 249 | 269 | 298 | 258 | 250 |
| aPTT (s) | 26 | 26.4 | 31.1 | 27.8 | 26.6 | 28.3 | 28.8 | 22.9 | 34.3 | 29.7 | 30.1 |
| PT (s) | 16.1 | 11.9 | 11.3 | 10.9 | 12.8 | 14.6 | 13.1 | 11.5 | 12.2 | 13.1 | 13.1 |
| Albumin (g/L) | 3.3 | 3.7 | 3.2 | 3.7 | 3.7 | 2.7 | 4.1 | NA | 3.8 | NA | 4.7 |
| ALT (U/L) | 10 | 17 | 22 | 24 | 62 | 95 | 10 | 15 | 11 | 13 | 35 |
| AST (U/L) | 22 | 18 | 31 | 24 | 73 | 27 | 15 | 24 | 18 | 19 | 26 |
| Total bilirubin (mg/dL) | NA | 0.75 | 0.77 | 0.67 | 0.78 | 0.42 | NA | 0.68 | NA | 0.48 | NA |
| Blood urea nitrogen (mg/dL) | 56 | 47 | 44 | 51 | 32 | 28 | 33 | 54 | 15 | 35 | 46 |
| Creatinine (mg/dL) | 1.44 | 0.88 | 0.54 | 0.59 | 1.08 | 0.37 | 0.7 | 0.72 | 0.49 | 0.64 | 0.84 |
| C-reactive protein (mg/dL) | 0.70 | 1.45 | 0.75 | 0.39 | 1.41 | 2.76 | 0.24 | 0.27 | 0.75 | 0.24 | 0.39 |
| IL-6 (pg/mL) | NA | NA | NA | NA | NA | 17.1 | NA | 72.7 | NA | 25.23 | NA |
| D-dimer (ng/mL) | NA | NA | NA | NA | NA | 710 | NA | 7780 | NA | 4743 | NA |
| SARS-CoV-2 quantitative RT-PCR | NA | NA | NA | NA | Negative | Positive | Negative | Negative | Negative | Negative | Negative |
| Chest X-ray | Lungs and pleural spaces were clear | Lungs and pleural spaces were clear | Lungs and pleural spaces were clear | Lungs and pleural spaces were clear | Lungs and pleural spaces were clear | Unilateral patchy consolidation | Lungs and pleural spaces were clear | Lungs and pleural spaces were clear | Lungs and pleural spaces were clear | Lungs and pleural spaces were clear | Lungs and pleural spaces were clear |
ASA, American Society of Anesthesiologists; aPTT, activated partial thromboplastin time; PT, prothrombin time; ALT, alanine aminotransferase; AST, aspartate aminotransferase; IL, interleukin; RT-PCR, reverse transcription polymerase chain reaction; HBP, high blood pressure; DLP, dyslipidemia; A-fib, atrial fibrillation; rTSA, reverser total shoulder arthroplasty; ORIF, open reduction and internal fixation; BHP, benign prostatic hyperplasia; PFF, proximal femoral fracture. All dates listed are 2020.